샘플 요청 목록

 카트 문의
시장보고서
상품코드
1777557

세계의 싱글셀 오믹스 시장

Single-Cell Omics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 389 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 싱글셀 오믹스 시장은 2030년까지 43억 달러에 이를 전망

2024년에 18억 달러로 추정되는 싱글셀 오믹스 세계 시장은 분석 기간인 2024-2030년 CAGR 15.4%로 성장하여 2030년에는 43억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 싱글셀 유전체학은 CAGR 17.8%를 나타내고, 분석 기간 종료까지 21억 달러에 이를 것으로 예측됩니다. 싱글셀 전사체학 분야의 성장률은 분석 기간중 CAGR13.3%로 추정됩니다.

미국 시장은 4억 9,880만 달러로 추정, 중국은 CAGR20.9%로 성장 예측

미국의 싱글셀 오믹스 시장은 2024년에는 4억 9,880만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 분석 기간인 2024-2030년간 CAGR 20.9%로 2030년까지 예측 시장 규모 9억 5,880만 달러에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 11.2%와 14.0%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 약 12.3%를 나타낼 전망입니다.

세계 싱글셀 오믹스 시장 - 주요 동향 및 촉진요인 정리

싱글셀 오믹스가 생의학 연구를 어떻게 변화시킬 것인가? 정밀의료와 질병 이해에 있어서의 역할에 대해 알아봅니다.

단일 세포학 분야는 과학자들이 대량의 세포 집단으로부터의 신호를 평균화하는 대신 개별 세포의 분자 및 유전적 특성을 분석할 수 있게 함으로써 생의학 연구에 혁명을 일으켰습니다. 이 접근법은 세포의 이질성에 대한 전례 없는 통찰력을 제공하여 연구자들이 희귀한 세포 집단을 연구하고, 질병의 진행을 추적하고, 새로운 치료 표적을 발견할 수 있게 해줍니다. 싱글셀 오믹스은 단일세포유전체학, 전사체학, 단백질체학, 대사체학 등 여러 분야를 아우르며, 이 모든 분야는 세포 기능에 대한 보다 종합적인 이해에 기여합니다. 이러한 기술은 세포의 다양성이 질병 메커니즘에서 중요한 역할을 하는 종양학, 면역학, 신경과학, 재생의학 분야에서 특히 유용하게 활용되고 있습니다. 세포의 고해상도 프로파일링을 가능하게 함으로써, 싱글셀오믹스는 연구자들이 보다 정밀한 치료법을 개발할 수 있도록 돕고, 정밀의료로 가는 길을 열어주고 있습니다. 개인 맞춤형 헬스케어에 대한 과학적 관심이 높아짐에 따라 첨단 단일 세포 분석 도구에 대한 수요는 지속적으로 확대되고 있으며, 이는 시장 성장을 가속하고 있습니다.

싱글셀오믹스를 강화하는 기술 발전이란? 데이터 분석 및 기기 혁신의 데이터 분석 및 검증

최근 시퀀싱 기술, 마이크로플루이딕스공학, 바이오인포매틱스의 발전은 단일 세포학 연구의 효율성과 확장성을 크게 향상시키고 있습니다. 차세대 시퀀싱(NGS) 플랫폼은 액적층 및 마이크로플루이딕스를 이용한 세포 분리 기술과 결합하여, 하이스루풋 단일 세포 분석이 가능하며, 수천 개의 세포를 동시에 처리할 수 있습니다. 인공지능(AI)과 머신러닝(ML)도 데이터 분석을 강화하는 데 중요한 역할을 하고 있으며, 연구자들은 방대하고 복잡한 데이터 세트에서 의미 있는 생물학적 통찰력을 도출할 수 있게 되었습니다. 또한, 유전체학, 단백질체학, 대사체학 데이터를 함께 분석하는 멀티오믹스 접근법의 통합으로 세포의 거동을 보다 총체적으로 파악할 수 있게 되었습니다. 이러한 기술 혁신을 통해 조사 기술의 재현성, 민감도, 비용 효율성이 개선되어 학술 연구, 임상 연구 등 모든 분야에서 보다 쉽게 활용할 수 있게 되었습니다. 기술이 계속 발전함에 따라 단일 세포 분석 툴은 더욱 정교해져 신약 개발 및 질병 모델링에 대한 적용이 확대될 것으로 예측됩니다.

싱글셀오믹스 도입의 걸림돌은 무엇인가? 비용, 복잡성, 데이터 분석의 문제 해결

싱글셀 오믹스는 그 혁신적 가능성에도 불구하고 높은 비용, 기술적 복잡성, 데이터 분석의 한계 등 여러 가지 문제에 직면해 있습니다. 단일세포 분석 및 멀티오믹스 프로파일링에 필요한 장비와 시약은 여전히 고가이며, 자원에 제약이 있는 연구 환경에서의 활용을 제한하고 있습니다. 또한, 바이어스나 아티팩트를 도입하지 않고 단일 세포를 분리-처리하는 데 필요한 기술적 전문 지식은 많은 연구소에서 어려움을 겪고 있는 실정입니다. 단일 세포학 연구에서 생성되는 방대한 양의 데이터는 계산상의 문제를 야기하며, 이를 효율적으로 저장하고 분석하기 위해서는 고도의 생물정보학 툴과 클라우드 기반 플랫폼이 필요합니다. 실험 프로토콜과 데이터 분석의 표준화는 여전히 중요한 과제인데, 기술의 편차가 연구마다 일관성 없는 결과를 초래할 수 있기 때문입니다. 이러한 과제를 해결하기 위해서는 비용 효율적인 기술에 대한 지속적인 투자, 계산 툴의 개선, 그리고 연구의 신뢰성과 재현성을 보장하기 위한 표준화된 워크플로우가 필요합니다.

싱글셀 오믹스 시장의 성장을 가속하는 요인은 무엇인가? 주요 확대 요인 및 산업 동향 파악

단일세포체 시장의 성장은 정밀의료 연구에 대한 자금 지원 증가, 시퀀싱 기술의 발전, 암 및 신경퇴행성 질환과 같은 복잡한 질환의 유병률 증가 등 여러 요인에 의해 이루어지고 있습니다. 정부 및 민간 기관은 생물의학 발견 및 의약품 개발을 가속화하기 위해 단일 세포 분석 툴에 많은 투자를 하고 있습니다. 또한, 질병의 조기 발견과 바이오마커 탐색에 대한 니즈가 증가하면서 임상 연구 및 진단에 싱글셀 오믹스의 도입이 가속화되고 있습니다. 단일 셀 데이터 분석에 AI와 클라우드 컴퓨팅을 통합함으로써 워크플로우가 더욱 간소화되고, 이러한 기술은 더 넓은 범위에서 활용될 수 있게 되었습니다. 또한, 제약사들은 표적치료제 개발 및 맞춤치료 전략에 싱글셀오믹스를 활용하여 시장의 상업적 가능성을 확장하고 있습니다. 기술의 발전과 정밀의료에 대한 수요가 증가함에 따라, 단일 세포학 시장은 크게 성장하여 질병을 조사하고 세포 수준에서 치료하는 방법에 혁명을 가져올 것입니다.

부문

제품 유형(싱글셀 유전체학, 싱글셀 전사체학, 싱글셀 단백질체학, 싱글셀 대사체학), 용도(종양학, 세포생물학, 신경학, 면역학), 최종 용도(제약 기업 및 바이오테크놀러지 기업, 학술기관 및 연구기관,병원 및 진단실험실, 기타)

조사 대상 기업 예

  • 10x Genomics
  • Agilent Technologies Inc.
  • ANGLE plc
  • Becton, Dickinson and Company(BD)
  • BGI Genomics Co. Ltd
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne
  • Celldom, Inc.
  • CELLENION
  • CYTENA GmbH
  • Danaher Corporation
  • Dolomite Bio
  • Epicypher Inc.
  • Fluidigm Corporation
  • Fluxion Biosciences
  • Illumina, Inc.
  • Miltenyi Biotec B.V. & Co. KG
  • Mission Bio, Inc.
  • NanoString Technologies, Inc.
  • Pacific Biosciences
  • PerkinElmer Inc.
  • Proteona
  • QIAGEN N.V.
  • Scipio Bioscience
  • Single Cell Discoveries
  • Singleron Biotechnologies
  • Singulomics
  • Standard BioTools Inc.
  • Takara Bio Group
  • Thermo Fisher Scientific

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.01

Global Single-Cell Omics Market to Reach US$4.3 Billion by 2030

The global market for Single-Cell Omics estimated at US$1.8 Billion in the year 2024, is expected to reach US$4.3 Billion by 2030, growing at a CAGR of 15.4% over the analysis period 2024-2030. Single-Cell Genomics, one of the segments analyzed in the report, is expected to record a 17.8% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the Single-Cell Transcriptomics segment is estimated at 13.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$498.8 Million While China is Forecast to Grow at 20.9% CAGR

The Single-Cell Omics market in the U.S. is estimated at US$498.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$958.8 Million by the year 2030 trailing a CAGR of 20.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.2% and 14.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.3% CAGR.

Global Single-Cell Omics Market - Key Trends & Drivers Summarized

How Is Single-Cell Omics Transforming Biomedical Research? Exploring Its Role in Precision Medicine and Disease Understanding

The field of single-cell omics has revolutionized biomedical research by enabling scientists to analyze the molecular and genetic characteristics of individual cells, rather than averaging signals from bulk cell populations. This approach provides unprecedented insights into cellular heterogeneity, allowing researchers to study rare cell populations, track disease progression, and uncover new therapeutic targets. Single-cell omics encompasses multiple disciplines, including single-cell genomics, transcriptomics, proteomics, and metabolomics, all of which contribute to a more comprehensive understanding of cellular functions. These techniques have proven particularly valuable in oncology, immunology, neuroscience, and regenerative medicine, where cellular diversity plays a critical role in disease mechanisms. By enabling high-resolution profiling of cells, single-cell omics is helping researchers develop more targeted therapies, paving the way for precision medicine. As scientific interest in personalized healthcare grows, the demand for advanced single-cell analysis tools continues to expand, fueling market growth.

What Technological Advancements Are Enhancing Single-Cell Omics? Examining Innovations in Data Analysis and Instrumentation

Recent advancements in sequencing technologies, microfluidics, and bioinformatics have significantly improved the efficiency and scalability of single-cell omics studies. Next-generation sequencing (NGS) platforms, combined with droplet-based and microfluidic cell isolation techniques, have enabled high-throughput single-cell analysis, making it possible to process thousands of cells simultaneously. Artificial intelligence (AI) and machine learning (ML) have also played a critical role in enhancing data interpretation, allowing researchers to extract meaningful biological insights from vast and complex datasets. Additionally, the integration of multi-omics approaches, where genomics, proteomics, and metabolomics data are analyzed together, has provided a more holistic view of cellular behavior. These innovations have improved the reproducibility, sensitivity, and cost-effectiveness of single-cell omics technologies, making them more accessible for both academic and clinical research settings. As technology continues to evolve, single-cell analysis tools are expected to become even more sophisticated, expanding their applications in drug discovery and disease modeling.

What Challenges Are Hindering the Adoption of Single-Cell Omics? Addressing Cost, Complexity, and Data Interpretation Issues

Despite its transformative potential, the widespread adoption of single-cell omics faces several challenges, including high costs, technical complexity, and data analysis limitations. The instrumentation and reagents required for single-cell sequencing and multi-omics profiling remain expensive, limiting their accessibility in resource-constrained research environments. Additionally, the technical expertise needed to isolate and process single cells without introducing bias or artifacts poses a challenge for many laboratories. The massive volume of data generated by single-cell omics studies also presents computational challenges, requiring advanced bioinformatics tools and cloud-based platforms for efficient storage and analysis. Standardization across experimental protocols and data interpretation remains a key issue, as variability in techniques can lead to inconsistent results across different studies. Addressing these challenges requires continued investment in cost-effective technologies, improved computational tools, and standardized workflows to ensure the reliability and reproducibility of single-cell omics research.

What’s Driving the Growth of the Single-Cell Omics Market? Identifying Key Expansion Factors and Industry Trends

The growth in the single-cell omics market is driven by several factors, including increasing funding for precision medicine research, advancements in sequencing technology, and the rising prevalence of complex diseases such as cancer and neurodegenerative disorders. Governments and private organizations are heavily investing in single-cell analysis tools to accelerate biomedical discoveries and drug development. Additionally, the growing need for early disease detection and biomarker discovery has boosted the adoption of single-cell omics in clinical research and diagnostics. The integration of AI and cloud computing in single-cell data analysis has further streamlined workflows, making these technologies more accessible for a broader range of applications. Moreover, pharmaceutical companies are leveraging single-cell omics for targeted drug development and personalized treatment strategies, expanding the commercial potential of the market. With continued technological advancements and increasing demand for precision healthcare, the single-cell omics market is poised for substantial growth, revolutionizing how diseases are studied and treated at the cellular level.

SCOPE OF STUDY:

The report analyzes the Single-Cell Omics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics); Application (Oncology, Cell Biology, Neurology, Immunology); End-Use (Pharma & Biotech Companies, Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • 10x Genomics
  • Agilent Technologies Inc.
  • ANGLE plc
  • Becton, Dickinson and Company (BD)
  • BGI Genomics Co. Ltd
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne
  • Celldom, Inc.
  • CELLENION
  • CYTENA GmbH
  • Danaher Corporation
  • Dolomite Bio
  • Epicypher Inc.
  • Fluidigm Corporation
  • Fluxion Biosciences
  • Illumina, Inc.
  • Miltenyi Biotec B.V. & Co. KG
  • Mission Bio, Inc.
  • NanoString Technologies, Inc.
  • Pacific Biosciences
  • PerkinElmer Inc.
  • Proteona
  • QIAGEN N.V.
  • Scipio Bioscience
  • Single Cell Discoveries
  • Singleron Biotechnologies
  • Singulomics
  • Standard BioTools Inc.
  • Takara Bio Group
  • Thermo Fisher Scientific

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Single-Cell Omics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Focus on Cellular Heterogeneity in Disease Biology Throws the Spotlight on Single-cell Omics Technologies
    • Expansion of Oncology and Immunotherapy Research Drives Demand for High-Resolution Molecular Profiling Tools
    • OEM Innovation in Microfluidic and Droplet-Based Platforms Accelerates Throughput and Cell Recovery Rates
    • Growth in Spatial Transcriptomics and Epigenomics Techniques Spurs Multi-Omics Integration Across Modalities
    • OEM Development of Multiomic Assay Kits and Instrument Bundles Enhances Workflow Simplification
    • Regulatory Support for Precision Medicine and Companion Diagnostics Drives Clinical Application of Single-cell Omics
    • OEM Collaboration With Academic Research Institutes Expands Access to Cell Atlas and Reference Databases
    • Rising Adoption in Neurobiology, Developmental Biology, and Stem Cell Research Broadens Scientific Utility
    • OEM Investment in Single-cell Data Analysis Software and AI-Based Interpretation Platforms Enhances Biological Insight
    • Growth in Single-cell CRISPR Screening and Perturb-seq Expands Functional Genomics Capabilities
    • OEM Emphasis on Scalable, Automation-Compatible Platforms Supports Use in High-Throughput Labs
    • Expansion of National Genomic Initiatives Globally Boosts Infrastructure Funding for Single-cell Research
    • OEM Development of Sample Preservation and Cell Viability Enhancers Increases Usable Input Quality
    • Increasing Demand for Cell-to-Cell Variability Assessment in Drug Discovery Propels Platform Commercialization
    • OEM Strategies for Cost Reduction and Multiplexing Drive Affordability for Broader Lab Adoption
    • Rising Focus on Tumor Microenvironment Characterization Accelerates Demand for Single-cell Immune Profiling
    • OEM Integration of Cell Sorting and Isolation Capabilities Within Single Workflow Enhances Operational Efficiency
    • Growth in Biobanking and Longitudinal Studies Increases Need for Standardized Single-cell Assay Reproducibility
    • OEM Expansion Into Single-nucleus and FFPE-Compatible Protocols Broadens Clinical Sample Applicability
    • Focus on End-to-End Omics Solutions and Vendor Partnerships Drives Ecosystem Consolidation in Single-cell Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Single-Cell Omics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Single-Cell Omics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Single-Cell Omics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Single-Cell Omics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Single-Cell Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Single-Cell Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Single-Cell Genomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Single-Cell Transcriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Single-Cell Transcriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Single-Cell Transcriptomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Single-Cell Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Single-Cell Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Single-Cell Proteomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Single-Cell Metabolomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Single-Cell Metabolomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Single-Cell Metabolomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Academic & Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Academic & Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Academic & Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospital & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Cell Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Cell Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Cell Biology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Immunology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • JAPAN
    • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • CHINA
    • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • EUROPE
    • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Single-Cell Omics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Single-Cell Omics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Single-Cell Omics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • FRANCE
    • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • GERMANY
    • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Omics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Single-Cell Omics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Single-Cell Omics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • INDIA
    • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Single-Cell Omics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Single-Cell Omics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Single-Cell Omics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Single-Cell Omics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Single-Cell Omics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Single-Cell Omics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
  • AFRICA
    • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제